Literature DB >> 23666550

A novel method for the culture and polarized stimulation of human intestinal mucosa explants.

Katerina Tsilingiri1, Angelica Sonzogni, Flavio Caprioli, Maria Rescigno.   

Abstract

Few models currently exist to realistically simulate the complex human intestine's micro-environment, where a variety of interactions take place. Proper homeostasis directly depends on these interactions, as they shape an entire immunological response inducing tolerance against food antigens while at the same time mounting effective immune responses against pathogenic microbes accidentally ingested with food. Intestinal homeostasis is preserved also through various complex interactions between the microbiota (including food-associated beneficial bacterial strains) and the host, that regulate the attachment/degradation of mucus, the production of antimicrobial peptides by the epithelial barrier, and the "education" of epithelial cells' that controls the tolerogenic or immunogenic phenotype of unique, gut-resident lymphoid cells' populations. These interactions have been so far very difficult to reproduce with in vitro assays using either cultured cell lines or peripheral blood mononuclear cells. In addition, mouse models differ substantially in components of the intestinal mucosa (mucus layer organization, commensal bacteria community) with respect to the human gut. Thus, studies of a variety of treatments to be brought in the clinics for important stress-related or pathological conditions such as irritable bowel syndrome, inflammatory bowel disease or colorectal cancer have been difficult to carry out. To address these issues, we developed a novel system that enables us to stimulate explants of human intestinal mucosa that retain their in situ conditioning by the host microbiota and immune response, in a polarized fashion. Polarized apical stimulation is of great importance for the outcome of the elicited immune response. It has been repeatedly shown that the same stimuli can produce completely different responses when they bypass the apical face of the intestinal epithelium, stimulating epithelial cells basolaterally or coming into direct contact with lamina propria components, switching the phenotype from tolerogenic to immunogenic and causing unnecessary and excessive inflammation in the area. We achieved polarized stimulation by gluing a cave cylinder which delimited the area of stimulation on the apical face of the mucosa as will be described in the protocol. We used this model to examine, among others, differential effects of three different Lactobacilli strains. We show that this model system is very powerful to assess the immunomodulatory properties of probiotics in healthy and disease conditions.

Entities:  

Mesh:

Year:  2013        PMID: 23666550      PMCID: PMC3667689          DOI: 10.3791/4368

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  10 in total

Review 1.  Should probiotics be tested on ex vivo organ culture models?

Authors:  Katerina Tsilingiri; Maria Rescigno
Journal:  Gut Microbes       Date:  2012-06-20

2.  Probiotic and postbiotic activity in health and disease: comparison on a novel polarised ex-vivo organ culture model.

Authors:  Katerina Tsilingiri; Theolis Barbosa; Giuseppe Penna; Flavio Caprioli; Angelica Sonzogni; Giuseppe Viale; Maria Rescigno
Journal:  Gut       Date:  2012-02-01       Impact factor: 23.059

Review 3.  Critical appraisal of the current practice in murine TNBS-induced colitis.

Authors:  Anje A te Velde; Marleen I Verstege; Daniel W Hommes
Journal:  Inflamm Bowel Dis       Date:  2006-10       Impact factor: 5.325

4.  Crypt regeneration in adult human colonic mucosa during prolonged organ culture.

Authors:  P V Senior; C J Pritchett; J P Sunter; D R Appleton; A J Watson
Journal:  J Anat       Date:  1982-05       Impact factor: 2.610

5.  Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: prediction for in vivo efficacy.

Authors:  Erika Mileti; Gianluca Matteoli; Iliyan D Iliev; Maria Rescigno
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

6.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Marc Gh Besselink; Hjalmar C van Santvoort; Erik Buskens; Marja A Boermeester; Harry van Goor; Harro M Timmerman; Vincent B Nieuwenhuijs; Thomas L Bollen; Bert van Ramshorst; Ben Jm Witteman; Camiel Rosman; Rutger J Ploeg; Menno A Brink; Alexander Fm Schaapherder; Cornelis Hc Dejong; Peter J Wahab; Cees Jhm van Laarhoven; Erwin van der Harst; Casper Hj van Eijck; Miguel A Cuesta; Louis Ma Akkermans; Hein G Gooszen
Journal:  Lancet       Date:  2008-02-14       Impact factor: 79.321

7.  The ex vivo response of human intestinal mucosa to enteropathogenic Escherichia coli infection.

Authors:  Stephanie Schüller; Mark Lucas; James B Kaper; Jorge A Girón; Alan D Phillips
Journal:  Cell Microbiol       Date:  2008-12-30       Impact factor: 3.715

8.  Organ culture of mucosal biopsies of human small intestine.

Authors:  T H Browning; J S Trier
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

9.  Identification of NF-κB modulation capabilities within human intestinal commensal bacteria.

Authors:  Omar Lakhdari; Julien Tap; Fabienne Béguet-Crespel; Karine Le Roux; Tomas de Wouters; Antonietta Cultrone; Malgorzata Nepelska; Fabrice Lefèvre; Joël Doré; Hervé M Blottière
Journal:  J Biomed Biotechnol       Date:  2011-06-14

Review 10.  Functional cell models of the gut and their applications in food microbiology--a review.

Authors:  Avrelija Cencic; Tomaz Langerholc
Journal:  Int J Food Microbiol       Date:  2010-04-02       Impact factor: 5.277

  10 in total
  7 in total

1.  The Ex Vivo Colon Organ Culture and Its Use in Antimicrobial Host Defense Studies.

Authors:  S M Nashir Udden; Sumyya Waliullah; Melanie Harris; Hasan Zaki
Journal:  J Vis Exp       Date:  2017-02-13       Impact factor: 1.355

Review 2.  Reproducing the human mucosal environment ex vivo: inflammatory bowel disease as a paradigm.

Authors:  Kenneth D Swanson; Evangelos Theodorou; Efi Kokkotou
Journal:  Curr Opin Gastroenterol       Date:  2018-11       Impact factor: 3.287

3.  Validation and Optimization of an Ex Vivo Assay of Intestinal Mucosal Biopsies in Crohn's Disease: Reflects Inflammation and Drug Effects.

Authors:  Kasper Vadstrup; Elisabeth Douglas Galsgaard; Jens Gerwien; Marianne Kajbæk Vester-Andersen; Julie Steen Pedersen; Julie Rasmussen; Søren Neermark; Marianne Kiszka-Kanowitz; Teis Jensen; Flemming Bendtsen
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

4.  Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids.

Authors:  Magdalena Kasendra; Alessio Tovaglieri; Alexandra Sontheimer-Phelps; Sasan Jalili-Firoozinezhad; Amir Bein; Angeliki Chalkiadaki; William Scholl; Cheng Zhang; Hannah Rickner; Camilla A Richmond; Hu Li; David T Breault; Donald E Ingber
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

Review 5.  Current Perspectives on Gastrointestinal Models to Assess Probiotic-Pathogen Interactions.

Authors:  Mehreen Anjum; Arja Laitila; Arthur C Ouwehand; Sofia D Forssten
Journal:  Front Microbiol       Date:  2022-01-31       Impact factor: 5.640

Review 6.  Microfluidic Organ-on-a-Chip Models of Human Intestine.

Authors:  Amir Bein; Woojung Shin; Sasan Jalili-Firoozinezhad; Min Hee Park; Alexandra Sontheimer-Phelps; Alessio Tovaglieri; Angeliki Chalkiadaki; Hyun Jung Kim; Donald E Ingber
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-04-24

Review 7.  Health-Promoting Properties of Proanthocyanidins for Intestinal Dysfunction.

Authors:  Carlos González-Quilen; Esther Rodríguez-Gallego; Raúl Beltrán-Debón; Montserrat Pinent; Anna Ardévol; M Teresa Blay; Ximena Terra
Journal:  Nutrients       Date:  2020-01-02       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.